December 11, 2025
āNo disease that can be treated by diet should be treated with any other means.āā Maimonides, 12th century physician
āThe solution to cancer is not in finding new ways to destroy, but in finding new ways to restore.āā Dr. Thomas Seyfried, Boston College
āIt is difficult to get a man to understand something when his salary depends upon his not understanding it.āā Upton Sinclair
[2024: Global oncology market surpasses $200 billion annually]
[Part 6 of 6]
Series finale
Genetics failed. Fifty years and trillions of dollars into the āWar on Cancer,ā mortality rates have barely budged. Glioblastoma patients die on the same timeline they did in the 1970s. Metastatic cancer remains incurable under standard protocols.
But thereās a man in Boston who figured it out.
Dr. Thomas Seyfried at Boston College has spent decades doing what the cancer establishment refuses to do: following Otto Warburgās discovery to its logical conclusion. Not chasing genetic complexity. Not inventing new ways to describe the chaos inside dying cells. Just asking the simple, uncomfortable question: What if cancer is what happens when cells canāt breathe?
What if everything else is just noise?
Heās not alone in asking. Heās alone in being right.
The evidence is overwhelming. The biochemistry is elegant. The clinical results are undeniable. Glioblastoma patients who should be dead are alive. Stage 4 lymphomas that recurred four times stop recurring. Metabolic interventions work.
They work, and theyāre being ignored.
Not because the science is weak. Because the economics are wrong.
The Simple Truth: Fermentation Is the Root
Hereās what Seyfried knows that the cancer industry pretends not to understand:
Cancer isnāt primarily a genetic disease. Itās a disease of damaged cellular respiration.
When mitochondria sustain chronic damage from inflammation, carcinogens, radiation, or metabolic stress, cells revert to an evolutionarily ancient survival mechanism: fermentation.¹ This is the same process yeast uses to make alcohol. Itās far less efficient than respiration, but it keeps the cell alive when normal energy production fails.
The problem is that fermentation uncouples the cell from the bodyās regulatory signals. Growth control depends on respiration being intact. When cells switch to fermentation as their primary energy source, they escape the constraints that normally prevent uncontrolled proliferation.²
The genomic chaos we see in cancer (the thousands of mutations catalogued by genetic researchers spending billions of dollars) is downstream debris. Itās the noise of a system collapsing, not the cause of the collapse.³
Seyfried proved this. Nuclear transfer experiments show that when you put a cancer cell nucleus into a healthy egg with functional mitochondria, you donāt get cancer. When you put a healthy nucleus into cytoplasm with damaged mitochondria, you do.ā“
The nucleus doesnāt matter. The mitochondria matter.
This is not controversial biology. This is basic biochemistry that every medical student learns and then forgets the moment they enter a system that profits from complexity.
The Press-Pulse: Beautiful, Elegant, Lethal
If cancer cells depend on fermentation, you restrict their fuel. But thereās a complication: they can ferment both glucose and glutamine. Cut off one, they switch to the other.
Seyfriedās solution is what he calls the Press-Pulse strategy, borrowing terminology from geology.āµ
The Press: A restricted ketogenic diet that chronically lowers blood glucose and insulin. This creates continuous metabolic stress on cancer cells while allowing normal cells to adapt by burning ketones. The press doesnāt kill cancer cells outright. It weakens them. It slows them. It backs them into a metabolic corner where they have no room to adapt.ā¶
The Pulse: Targeted interventions that deliver acute stress cancer cells cannot survive.
* Glutamine inhibitors like DON that block their backup fuelā·
* Hyperbaric oxygen therapy that overwhelms their damaged mitochondriaāø
* Repurposed metabolic drugs like metformin that interfere with fermentationā¹
* Stress management to lower cortisol and stop internal glucose production¹ā°
The press weakens. The pulse kills.
Normal cells, with intact mitochondria and metabolic flexibility, weather both interventions with minimal harm. Cancer cells, locked into fermentation, cannot adapt.
Itās beautiful. Itās elegant. Itās lethal to cancer.
And it costs almost nothing.
The GBM Patient Who Refused to Die
Glioblastoma multiforme is the most aggressive brain tumor humans get. Standard treatment (surgery, radiation, temozolomide chemotherapy) offers median survival of 12-15 months. Five-year survival is under 10%. Itās considered uniformly fatal.¹¹
The oncology establishment has accepted this. They manage symptoms. They extend life by weeks. They tell families to prepare.
A 38-year-old woman with GBM didnāt accept it.
She went on a calorically restricted ketogenic diet combined with hyperbaric oxygen and metabolic drugs. Her tumor regressed. She survived over 24 months in excellent health with no recurrence.¹² Not managing symptoms. Not buying weeks. Thriving.
Far exceeding statistical expectations isnāt the right phrase. She shattered them. She shouldnāt exist according to the genetic paradigm.
But she does. Because cancer is metabolic.
Systematic reviews confirm the pattern. Ketogenic diets in glioma treatment show consistent improvements in progression-free survival and quality of life compared to standard chemotherapy.¹³ Patients report better cognitive function, less fatigue, fewer debilitating side effects.
Animal studies provide controlled confirmation. Mice with metastatic cancer treated with ketogenic diet plus hyperbaric oxygen showed significantly prolonged survival compared to controls receiving standard care or either intervention alone.¹ā“
The evidence is there. The mechanism is clear. The clinical results are undeniable.
Seyfried published it. The journals accepted it. The system ignored it.
I Watched His Spleen Shrink
My friend had stage 4 lymphoma. Chemotherapy alone failed him four times over seven years. Each recurrence came back more aggressive. The pattern was relentless: 1.75 years, cancer returns, treat again, repeat.
When I introduced metabolic interventions (high-dose liposomal vitamin C, intermittent fasting, carbohydrate restriction), his massively swollen spleen began shrinking.
I watched it happen. Not in a clinical trial. Not in a controlled study. In real time, in a man who had run out of options.
The mechanism is called differential stress resistance. Normal cells in nutritional ketosis activate protective pathways that shield them from chemotherapyās toxicity. Cancer cells, locked into fermentation and unable to metabolize ketones, become more vulnerable to the same drugs.¹āµ
This inverts the traditional calculation. Standard chemotherapy damages cancer and normal cells indiscriminately, hoping cancer cells are slightly more vulnerable. With metabolic therapy, the differential increases dramatically. Chemotherapy becomes a precision weapon instead of a blunt instrument.
Clinical trials testing this in breast cancer, ovarian cancer, and brain tumors show patients can tolerate higher chemotherapy doses with fewer side effects while achieving better tumor responses.¹ā¶
But we didnāt need a clinical trial. We needed metabolic pressure. Glucose restriction through fasting. Insulin suppression through carbohydrate elimination. High-dose vitamin C acting as a pro-oxidant specifically toxic to cancer cells.
His spleen shrank. The cancer stopped recurring. Five years later, heās still here.
Not because of genetic medicine. Not because of targeted immunotherapy. Not because of novel chemotherapy cocktails.
Because we stopped feeding the cancer and started protecting his mitochondria.
The Economic Barrier: Simplicity Doesnāt Pay
If metabolic therapy works, why isnāt it standard of care?
The answer is structural, not scientific.
Metabolic interventions are largely unpatentable. A ketogenic dā¦